Misinformation by Fact-Checkers: In-Depth Look at Another Hit Piece in Mainstream Media

Ivermectin is a scandal based on “shoddy science”, according to an article published in The Atlantic on October 23, 2021. TrialSite takes a closer, more in-depth look at the self-labeled “forensic peer review” research team, and fact-checks the fact-checkers to determine the validity of their claims.

The dissemination of critical information to the public by influencers on major media platforms in the COVID-19 era has been confounding, with no way to decipher half-truths from empirically supported facts. TrialSite has followed up on concerning circulations on media outlets that are not corroborated by experts of the subject matter of SARS-CoV-2. 

A group of individuals who maintain to have specialized expertise as forensic peer reviewers for clinical trial data has been circulating information about the drug ivermectin. They have been countering data from clinical trials and preprints, amplifying weaknesses both perceived and real, to dismiss any significant implications it may hold.

Though exercising free speech is a right, scientific arguments need comprehensive empirical support before being released publicly and in good faith to consumers. The Atlantic published ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee